Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa F Khouri

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic TransplantationMaria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndromeGheath Alatrash, Matteo Pelosini, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2002
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilizationJames L Gajewski, Gabriela Rondon, Michele L Donato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2019
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up ResultsKamal Chamoun, Denái R Milton, Celina Ledesma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell LymphomaJad Chahoud, Dawen Sui, William D Erwin, et al.
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell TransplantationBetül Oran, Antonio M Jimenez, Marcos De Lima, et al.
Bone Marrow Transplantation|October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic TransplantationMaria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndromeGheath Alatrash, Matteo Pelosini, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2002
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilizationJames L Gajewski, Gabriela Rondon, Michele L Donato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2019
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up ResultsKamal Chamoun, Denái R Milton, Celina Ledesma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell LymphomaJad Chahoud, Dawen Sui, William D Erwin, et al.
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell TransplantationBetül Oran, Antonio M Jimenez, Marcos De Lima, et al.
Bone Marrow Transplantation|October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Pageof 7